Therapy in primary mediastinal B-cell lymphoma

Comment

Wyndham H Wilson et al. N Engl J Med. 2013.

. 2013 Jul 18;369(3):283-4.

doi: 10.1056/NEJMc1305983.

No abstract available

Comment on

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.
Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J, Steinberg SM, Grant C, Wright G, Varma G, Staudt LM, Jaffe ES, Wilson WH. Dunleavy K, et al. N Engl J Med. 2013 Apr 11;368(15):1408-16. doi: 10.1056/NEJMoa1214561. N Engl J Med. 2013. PMID: 23574119 Free PMC article. Clinical Trial.
Therapy in primary mediastinal B-cell lymphoma.
Woessmann W, Lisfeld J, Burkhardt B; NHL-BFM Study Group. Woessmann W, et al. N Engl J Med. 2013 Jul 18;369(3):282. doi: 10.1056/NEJMc1305983. N Engl J Med. 2013. PMID: 23863060 No abstract available.
Therapy in primary mediastinal B-cell lymphoma.
Cashen AF, Christian BA, Bartlett NL. Cashen AF, et al. N Engl J Med. 2013 Jul 18;369(3):282-3. doi: 10.1056/NEJMc1305983. N Engl J Med. 2013. PMID: 23863061 No abstract available.